CG
Cognetivity Neurosciences Ltd.
CGNSF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $12.7K
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.28x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 4,694.86%
FCF margin 13,252.30%
Net margin 16,386.30%
Quality
57 /100
Average ROIC 97.17%
Asset turnover 0.02x
ROA 262.73%
Debt
50 /100
Moderate Current ratio 0.25x
Net debt/EBITDA 0.15x
Int. coverage -6.23x
Stability
37 /100
Moderate Beta 0.74x
Profitable years 0
EPS volatility 285.51%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CGNSF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Sina Habibi
Employees
2,500
Headquarters
Vancouver
Prihajajoči dogodki
05 OKT.
Earnings
Upcoming earnings report